期刊： APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022; 30 (6)
Transcription factor E3 (TFE3) represents a useful target for immunohistochemistry assays in routine surgical pathology practice. This protein has sho......
期刊： APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022; 30 (6)
Background: Distinction of superficial spreading melanoma (SSM) from compound nevi (CN) sometimes poses difficult diagnostic challenges. Herein, we st......
期刊： APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022; 30 (7)
Colorectal cancer (CRC) is the third most common cancer worldwide. Although clinical outcome varies among patients diagnosed within the same TNM stage......
期刊： APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022; 30 (4)
Histopathologic examination of highly pigmented melanoma tissues has always been a challenge for pathologists. The high concentration of melanin pigme......
期刊： APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022; 30 (5)
Immunohistochemistry for Uroplakin (UP) II and III is used to determine urothelial origin of carcinomas of unknown primary site and are especially val......
期刊： APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022; 30 (5)
Background: Severe acute respiratory syndrome coronavirus 2 causes diffuse alveolar damage (DAD), lymphocyte infiltration in the lungs and a cytokine ......
期刊： APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022; 30 (10)
Melanoma is the cutaneous neoplasm responsible for more patient deaths in all countries. BRAF mutations are the most common driver mutation and with t......
期刊： APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022; 30 (4)
The nail plate is one of the essential structures of the nail apparatus and is highly keratinized, making it difficult to handle this tissue experimen......
期刊： APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022; 30 (9)
Tumor genomic profiling represents a promising tool in diagnosis and management of cancer of unknown primary. We report our experience on the impact o......
期刊： APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022; 30 (1)
Undifferentiated malignant neoplasms pose diagnostic challenges, and reliable immunohistochemical markers with well-characterized staining profiles ar......
期刊： APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022; 30 (9)
Low-grade fibromyxoid sarcoma is an uncommon soft tissue malignant neoplasm with deceptively bland histologic appearance, and a tendency for late recu......
期刊： APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022; 30 (1)
Giant cell tumor of bone (GCTB) is a benign neoplasm, which can sometimes be a diagnostic challenge, especially in small biopsies, due to its histolog......
期刊： APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022; 30 (4)
Secretory carcinoma (SC) is a low-grade salivary gland carcinoma characterized by recurrent ETV6 rearrangements. Most cases have ETV6-NTRK3 fusions, w......
期刊： APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022; 30 (8)
Objective: Adult granulosa cell tumors (AGCTs) are rare ovarian malignant neoplasms; their etiopathogenetic mechanisms remain largely unelucidated. La......
期刊： APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022; 30 (8)
Atezolizumab in combination with nab-paclitaxel has been introduced for the treatment of locally advanced or recurrent triple negative breast cancer (......
